Status:
UNKNOWN
Non-invasive Assessment of Mechano-chemical Properties of Urine Proteins by Hybrid Brillouin-Raman Spectroscopy
Lead Sponsor:
Nazarbayev University
Collaborating Sponsors:
National Scientific Medical Center, Kazakhstan
Astana Medical University
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
The proteinuria is widely recognized as a marker of kidney disease severity, as well as the predictor of renal function decline, cardiovascular outcomes, and all-cause mortality. However, the severity...
Eligibility Criteria
Inclusion
- Both male and female patients with any ethnic group, aged between 18-65 years old
- Newly diagnosed patients with glomerulonephritis and different range of proteinuria
Exclusion
- patients aged \<18 and \>65 years,
- eGFR\<60 ml/min,
- pregnant females,
- patients with diabetes mellitus, cancer, infectious diseases, and other life-treating comorbidities/conditions
Key Trial Info
Start Date :
April 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT04311684
Start Date
April 6 2020
End Date
December 1 2023
Last Update
November 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nazarbayev University School of Medicine
Astana, Kazakhstan, 010000